The neuregulin system of ligands and their receptors in rat islets of Langerhans

Endocrinology

Volumn 154, Issue 7, 2013, Pages 2385-2392

  South, Jack C M ^a   Blackburn, Edith ^a   Brown, Ian R ^a   Gullick, William John ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR; INSULIN; NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR 1ALPHA; NEU DIFFERENTIATION FACTOR 1BETA; NEU DIFFERENTIATION FACTOR 2ALPHA; NEU DIFFERENTIATION FACTOR 2BETA; NEU DIFFERENTIATION FACTOR 3; NEU DIFFERENTIATION FACTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL GROWTH; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; INSULIN; ISLETS OF LANGERHANS; MALE; NERVE GROWTH FACTORS; NEUREGULIN-1; NEUREGULINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84879303219     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2133     Document Type: Article

References (29)

1. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127-137. (Pubitemid 33674041)
2. Montero JC, Rodríguez-Barrueco R, Ocaña A, Díaz-Rodríguez E, Esparís-Ogando A, Pandiella A. Neuregulins and cancer. Clin Cancer Res. 2008;14:3237-3241.
3. Harrison PJ, Law AJ. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatr. 2006;60:132-140.
4. Hayes NV, Gullick WJ. The Neuregulin family of genes and their multiple splice variants in breast cancer. J Mammary Gland Biol Neoplasia. 2008;13:205-214.
5. Steinthorsdottir V, Stefansson H, Ghosh S, et al. Multiple novel transcription initiation sites for NRG1. Gene. 2004;342:97-105. (Pubitemid 39457182)
6. Hayes NV, Blackburn E, Smart LV, et al. Identification and characterization of novel spliced variants of neuregulin 4 in prostate cancer. Clin Cancer Res. 2007;13:3147-3155. (Pubitemid 46944896)
7. Dunn M, Sinha P, Campbell R, et al. Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancer. J Pathol. 2004;203:672-680. (Pubitemid 38714104)
8. Marshall C, Blackburn E, Clark M, Humphreys S, Gullick WJ. Neuregulins 1-4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast. Breast Cancer Res Treat. 2006;96:163-168.
9. Hayes NL, Blackburn E, Boyle MM, et al. Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility. Endocr Relat Cancer. 2010;18:39-49.
10. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, et al. Molecular control of cell cycle progression in the pancreatic β-cell. Endocr Rev. 2006;27:356-370. (Pubitemid 43848303)
11. Lee YC, Neilsen JH. Regulation of β cell replication. Mol Cell Endocrinol. 2009;297:18-27.
12. Buteau J, Foisy S, Joly E, Prentki M. Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor. Diabetes. 2003;52:124-132. (Pubitemid 36042116)
13. Miettinen PJ, Huotari M, Koivisto T, et al. Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development. 2000;127:2617-2627. (Pubitemid 30426809)
14. Miettinen PJ, Ustinov J, Ormio P, et al. Downregulation of EGF receptor signalling in pancreatic islets causes diabetes due to impaired postnatal β-cell growth. Diabetes. 2006;55:3299-3308. (Pubitemid 44923586)
15. Erickson SL, O'Shea KS, Ghaboosi N, et al. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2 and heregulin-deficient mice. Development. 1997;124:4999-5011. (Pubitemid 28025125)
16. Sasada R, Ono Y, Taniyama Y, Shing Y, Folkman J, Igarashi K. Cloning and expression of cDNA encoding human Betacellulin, a new member of the EGF family. Biochem Biophys Res Commun. 1993;190:1173-1179. (Pubitemid 23207889)
17. Mashima H, Shibata H, Mine T, Kojima I. Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology. 1996;137:3969-3976. (Pubitemid 26284673)
18. Krakowski ML, Kritzik MR, Jones EM, et al. Transgenic expression of epidermal growth factor and keratinocyte growth factor in β-cells results in substantial morphological changes. J Endocrinol. 1999;162:167-175. (Pubitemid 29369163)
19. Huotari MA, Miettinen PJ, Palgi J, et al. ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture. Endocrinology. 2002;143:4437-4446. (Pubitemid 35239578)
20. McIntyre E, Blackburn E, Brown PJ, Johnson CG, Gullick WJ. The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancer. Breast Cancer Res Treat. 2010;122:105-110.
21. Harvey J, Ashford ML. Insulin occludes leptin activation of ATP-sensitive K+ channels in rat CRI-G1 insulin secreting cells. J Physiol 1998;511:695-706. (Pubitemid 28456900)
22. Pawlowski V, Révillion F, Hebbar M, Hornez L, Peyrat JP. Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res. 2000;6:4217-4225.
23. Arai KY, Tsuchida K, Uehara K, Taya K, Sugino H. Characterization of rat follistatin-related gene: effects of estrous cycle stage and pregnancy on its messenger RNA expression in rat reproductive tissues. Biol Reprod 2003;68:199-206. (Pubitemid 36076337)
24. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 2006;103:2334-2339. (Pubitemid 43271670)
25. Jones JT, Akita RW, Sliwkowski MX. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 1999;447:227-231. (Pubitemid 29146091)
26. Harari D, Tzahar E, Romano J, et al. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene. 1999;18:2681-2689. (Pubitemid 29237656)
27. Wang M, Trim CM, Gullick WJ. Localisation of Neuregulin 1-β3 to different sub-nuclear structures alters gene expression. Ex Cell Res. 2011;317:423-432.
28. Hayes NV, Newsam RJ, Baines AJ, Gullick WJ. Characterization of the cell membrane-associated products of the Neuregulin 4 gene. Oncogene. 2008;27:715-720. (Pubitemid 351158899)
29. Mellado-Gil JM, Cobo-Vuilleumier N, Gauthier BR. Islet β-cell mass preservation and regeneration in diabetes mellitus: four factors with potential therapeutic interest. J Transplant. 2012;2012:230870.